Investigational (Inv) agents with or without pembrolizumab (pembro) or pembro alone in melanoma (mel): KEYMAKER-U02 Meeting Abstract
| Authors: | Dummer, R.; Long, G. V.; Pavlick, A. C.; Postow, M. A.; Ribas, A.; Robert, C.; Scolyer, R. A.; Taube, J. M.; Tetzlaff, M.; Su, S. C.; Singh, R.; Diede, S. J.; Tawbi, H. A. H. |
| Abstract Title: | Investigational (Inv) agents with or without pembrolizumab (pembro) or pembro alone in melanoma (mel): KEYMAKER-U02 |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S903 |
| Language: | English |
| ACCESSION: | WOS:000700527702110 |
| DOI: | 10.1016/j.annonc.2021.08.1477 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract #1092TiP -- Source: Wos |
